Back

A novel hyperinflammation clinical risk tool, HI5-NEWS2, predicts mortality following early dexamethasone use in an observational cohort of hospitalised COVID-19 patients.

2021-06-18 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundThe success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely that there is substantial heterogeneity in HI responses in COVID-19. MethodsBlood CRP, ferritin, neutrophil, lymphocyte and platelet counts were scored to assess HI (HI5) and combined with a validated measure of generalised medical deterioration (NEWS2) before day 2...

Predicted journal destinations

1
BMJ Open
553 training papers
Top 17% 8.4%
2
Nature Communications
483 training papers
Top 18% 6.0%
3
PLOS ONE
1737 training papers
Top 80% 5.5%
4
Clinical Infectious Diseases
219 training papers
Top 6% 5.5%
5
Scientific Reports
701 training papers
Top 59% 4.7%
6
New England Journal of Medicine
49 training papers
Top 0.6% 3.9%
7
The Lancet Respiratory Medicine
16 training papers
#1 3.6%
8
BMC Medicine
155 training papers
Top 7% 3.6%
9
Nature Medicine
88 training papers
Top 1% 2.8%
10
BMJ
49 training papers
Top 1% 2.0%
11
Journal of Infection
64 training papers
Top 2% 1.8%
12
PLOS Medicine
95 training papers
Top 6% 1.8%
13
JAMA Network Open
125 training papers
Top 11% 1.8%
14
Open Forum Infectious Diseases
124 training papers
Top 7% 1.8%
15
Frontiers in Immunology
140 training papers
Top 7% 1.8%
16
Clinical Microbiology and Infection
54 training papers
Top 2% 1.8%
17
The Journal of Infectious Diseases
137 training papers
Top 8% 1.8%
18
eLife
262 training papers
Top 25% 1.8%
19
eClinicalMedicine
55 training papers
Top 0.6% 1.8%
20
BMC Infectious Diseases
110 training papers
Top 13% 1.4%
21
JCI Insight
63 training papers
Top 5% 1.4%
22
Journal of Medical Virology
95 training papers
Top 8% 1.4%
23
Frontiers in Medicine
99 training papers
Top 15% 1.2%
24
eBioMedicine
82 training papers
Top 6% 1.2%
25
International Journal of Infectious Diseases
115 training papers
Top 16% 1.2%
26
The Lancet
16 training papers
#1 1.1%
27
The Lancet Infectious Diseases
57 training papers
Top 5% 1.1%
28
Journal of Infection and Public Health
15 training papers
Top 0.5% 0.9%
29
Clinical Pharmacology & Therapeutics
19 training papers
Top 1% 0.9%
30
British Journal of Clinical Pharmacology
21 training papers
Top 1% 0.9%